MyoKardia, a clinical-stage biopharmaceutical company discovering and developing targeted therapies for the treatment of serious cardiovascular diseases, was co-founded by Leslie Leinwand, Distinguished Professor of Molecular, Cellular, and Developmental Biology at °ÄÃÅ¿ª½±½á¹û2023¿ª½±¼Ç¼'s BioFrontiers Institute.